High-Quality Genomic Testing

Physicians may elect to order clinical genome sequencing for patients whose clinical presentations have defied diagnosis, or for whom a diagnosis doesn’t completely “fit” the symptoms or manifestation of the disease, and for which the cause appears genetic in origin. These patients will typically have seen a number of specialists and current therapies are unsuccessful in alleviating symptoms or providing a significant improvement in health. Patients also may have undergone a series of tests, often including testing of specific genes, prior to being a good candidate. Patients with a reliable and confirmed diagnosis will not be good candidates.

DNA Extraction and Storage

Clinical Genome Sequencing with Interpretation

Reanalysis & Reinterpretation

Global Screening Array + Interpretation

Targeted Variant Testing (Sanger Sequencing)

Institutional Services

This test(s) was developed, and performance characteristics were determined by the HudsonAlpha Clinical Services Lab, LLC. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.